These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37667968)

  • 21. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation.
    El-Salhy M; Winkel R; Casen C; Hausken T; Gilja OH; Hatlebakk JG
    Gastroenterology; 2022 Oct; 163(4):982-994.e14. PubMed ID: 35709830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan.
    Hamazaki M; Sawada T; Yamamura T; Maeda K; Mizutani Y; Ishikawa E; Furune S; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Nakamura M; Fujishiro M
    BMC Gastroenterol; 2022 Jul; 22(1):342. PubMed ID: 35836115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal Microbiota Transplantation Combined with a Low FODMAP Diet for the Treatment of Irritable Bowel Syndrome with Predominant Diarrhea.
    Huang HL; Zhu JQ; Yang LS; Wu Q; Shou DW; Chen HT; Ma J; Li YQ; Xu HM; Zhou YJ
    Oxid Med Cell Longev; 2022; 2022():5121496. PubMed ID: 36187337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study - a randomised, double-blind cross-over study using mixed microbiota from healthy donors.
    Hurych J; Vejmelka J; Hlinakova L; Kramna L; Larionov V; Kulich M; Cinek O; Kohout P
    BMJ Open; 2022 Jun; 12(6):e056594. PubMed ID: 35760542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy and safety of faecal microbiota transplantation in the treatment of irritable bowel syndrome: a systematic review, meta-analysis and trial sequential analysis.
    Lo SW; Hung TH; Lin YT; Lee CS; Chen CY; Fang CJ; Lai PC
    Eur J Med Res; 2024 Sep; 29(1):464. PubMed ID: 39289768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Wu J; Lv L; Wang C
    Front Cell Infect Microbiol; 2022; 12():827395. PubMed ID: 35295757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS).
    El-Salhy M; Hausken T; Hatlebakk JG
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31238507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
    El-Salhy M; Mazzawi T; Hausken T; Hatlebakk JG
    Scand J Gastroenterol; 2022 Sep; 57(9):1036-1045. PubMed ID: 35486073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome.
    Ianiro G; Eusebi LH; Black CJ; Gasbarrini A; Cammarota G; Ford AC
    Aliment Pharmacol Ther; 2019 Aug; 50(3):240-248. PubMed ID: 31136009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal microbiota transplant delivered via invasive routes in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Mohan BP; Loganathan P; Khan SR; Garg G; Muthusamy A; Ponnada S; Pasam RT; Chandan S; Tuteja A
    Indian J Gastroenterol; 2023 Jun; 42(3):315-323. PubMed ID: 37247177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
    El-Salhy M; Valeur J; Hausken T; Gunnar Hatlebakk J
    Neurogastroenterol Motil; 2021 Feb; 33(2):e13983. PubMed ID: 32945066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study.
    Madsen AMA; Halkjær SI; Christensen AH; Günther S; Browne PD; Kallemose T; Hansen LH; Petersen AM
    Scand J Gastroenterol; 2021 Jul; 56(7):761-769. PubMed ID: 34000958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial.
    Johnsen PH; Hilpüsch F; Valle PC; Goll R
    EBioMedicine; 2020 Jan; 51():102562. PubMed ID: 31877418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
    Kurokawa S; Kishimoto T; Mizuno S; Masaoka T; Naganuma M; Liang KC; Kitazawa M; Nakashima M; Shindo C; Suda W; Hattori M; Kanai T; Mimura M
    J Affect Disord; 2018 Aug; 235():506-512. PubMed ID: 29684865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome.
    Holster S; Repsilber D; Geng D; Hyötyläinen T; Salonen A; Lindqvist CM; Rajan SK; de Vos WM; Brummer RJ; König J
    Benef Microbes; 2021 Feb; 12(1):17-30. PubMed ID: 33350360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of fecal microbiota transplantation for irritable bowel syndrome.
    El-Salhy M; Hausken T; Hatlebakk JG
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14157. PubMed ID: 34236740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Jamshidi P; Farsi Y; Nariman Z; Hatamnejad MR; Mohammadzadeh B; Akbarialiabad H; Nasiri MJ; Sechi LA
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
    Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
    Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation.
    El-Salhy M; Mazzawi T; Hausken T; Hatlebakk JG
    Neurogastroenterol Motil; 2022 Sep; 34(9):e14353. PubMed ID: 35302268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.